Home › Funds › BROOKTREE CAPITAL MANAGEMENT › AMGN

BROOKTREE CAPITAL MANAGEMENT position in AMGN

AMGEN INC · Health Care

BROOKTREE CAPITAL MANAGEMENT reported holding 1,000 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$422K, representing 0.29% of its reported portfolio and ranking #33 among its reported holdings. BROOKTREE CAPITAL MANAGEMENT has disclosed AMGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.00K sh
Reported value held$421.51K
Portfolio Weight0.29%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROOKTREE CAPITAL MANAGEMENT's AMGN position evolved

BROOKTREE CAPITAL MANAGEMENT first disclosed a stake in AMGN in Q2 2025 at 1,000 shares (US$279K). The position peaked in Q3 2026 at 1,000 shares, worth US$422K. Across 6 filings, BROOKTREE CAPITAL MANAGEMENT held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,000 shares valued at US$422K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.00K $279.21K New
Q3 2025 1.00K $282.20K Hold
Q4 2025 1.00K $327.31K Hold
Q1 2026 1.00K $351.85K Hold
Q2 2026 1.00K $362.12K Hold
Q3 2026 1.00K $421.51K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 30 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), VANGUARD CAPITAL MANAGEMENT LLC (US$14.92B), STATE STREET CORP (US$13.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has BROOKTREE CAPITAL MANAGEMENT held AMGN?

BROOKTREE CAPITAL MANAGEMENT has disclosed AMGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is BROOKTREE CAPITAL MANAGEMENT's current position in AMGN?

As of Q3 2026, BROOKTREE CAPITAL MANAGEMENT holds 1.00K shares of AMGN (AMGEN INC), valued at $421.51K, representing 0.29% of its reported portfolio and ranking #33.

Has BROOKTREE CAPITAL MANAGEMENT been buying or selling AMGN?

In the latest 13F filing (Q3 2026), BROOKTREE CAPITAL MANAGEMENT held unchanged its position in AMGN. The position peaked in Q3 2026 at 1.00K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.